Sprout Pharmaceuticals, which makes the only FDA-approved drug for female sexual disfunction often called “Viagra” for women, has raised a debt round.
Read More
Antifungal developer Mycovia seeks FDA approval for its first drug, a treatment for yeast infections.
Read More
Its CEO Richard Hullihen said the system could potentially reach millions of patients in need of a novel tool to better understand their lung disease – including those suffering from the lingering effects of COVID-19.
Read More
The first video game-based treatment for attention deficit hyperactivity disorder (ADHD) has been approved by the US Food and Drug Administration (FDA).
Read More
A warning from the FDA says that 97% of drugs sold through online pharmacies are fake or not approved by the government. Because of the coronavirus pandemic, buy of medication online has skyrocketed.
Read More
The US Food and Drug Administration will now require antibody test makers to promptly seek FDA authorization, as the agency aims to rein in unproven and fraudulent tests that have flooded the market.
Read More
The FDA has OK’d the use of the drug tucatinib, or Tukysa, in combination with chemotherapy, for the treatment of adults with advanced forms of HER2-positive breast cancer that either cannot be removed with surgery, or has spread to other parts of the body.
Read More
The US Food and Drug Administration is going after vaping company Eonsmoke LLC with a warning letter seeking to remove roughly 100 flavored vaping products from the market as the number of health cases linked to vaping continues to grow.
Read More
Cindy Eckert, CEO of Raleigh-based Sprout Pharmaceuticals, says the next step in an ongoing debate with the Food and Drug Administration about the firm’s female sexual dysfunction drug Addyi is up to the regulatory agency.
Read More
